HIGHLIGHTS
- who: Longhua Wang and colleagues from the Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, Out-patient Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China have published the research work: Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis, in the Journal: PLOS ONE of November/27,/2022
- what: The authors conducted a meta-analysis to examine the effectiveness and safety of WFC for CAG.
- how: The authors conducted a random effects model to examine pooled RR if significant heterogeneity existed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.